INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Our Unified Platform Serves As eSource For COVID Treatment Trial

  Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.

• Revitalizing Recruitment In A Lupus Rescue Study

  Recruitment hurdles are overcome by leveraging engaged, data-sharing patient communities. See how a strategic, patient-centric approach delivered a pre-qualified clinical trial cohort quickly and efficiently.

• Revolutionizing CRO Financial Management With Better Technology

  For contract research organizations (CROs), the reliance on Excel is giving way to specialized technology, marking a pivotal shift in financial management strategies.

• Driving Efficiency In Document Reviews With Structured Content

  Discover how integrating an innovative document review platform streamlines workflows, boosts compliance, and cuts review times by 65% from real-world Life Sciences case studies.

• eCOA Solution Design Recommendations: Applied Insights From Trial Sites, CRAs

  6/17/2024

  Enhance hybrid trials with digitalization through remote data capture using smartphones, tablets, and computers, improving participant experience and data integrity.

• A Guide For Quality Professionals In Healthcare And Life Sciences

  3/14/2025

  Discover a guide for quality professionals that highlights essential principles and strategies for maintaining data accuracy, compliance, and innovation to ensure high-quality data in healthcare and life sciences.

• Top HEOR Trends

  5/14/2025

  Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.

• Measure Critical Health Outcomes In GLP-1 And Related Obesity Treatments

  9/17/2024

  In this session of Digital Health Monthly, Dr. Glenn Gaesser shares his extensive research on the intersection of obesity and exercise physiology, emphasizing the importance of physical activity.

• What Happened At ASCO 2025?

  6/5/2025

  ASCO 2025 underscored both the momentum in oncology innovation and the critical need to protect the infrastructure that enables it—ensuring that tomorrow’s breakthroughs remain within reach for all patients.